Drug
Cbt124
Cbt124: highest development phase Phase 3, developed by Cipla. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Cipla
Trials
| Drug | Phase | Indication |
|---|---|---|
| CBT124 NCT02879097 | Phase 3 | Non-Small Cell Lung Carcinoma |
| CBT124 NCT02747823 | Phase 1 | Healthy |
Latest
No recent events.
Follow Cbt124 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.